As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Eli Lilly and Company: Simplex Trading LLC, Bank of New York Mellon Corp, Mission Wealth Management LP, Wolverine Asset Management LLC, Allianz Asset Management GmbH, Twin Tree Management LP, Johnson Investment Counsel Inc., Brandywine Oak Private Wealth LLC, US Bancorp DE, Valeo Financial Advisors LLC, IMC Chicago LLC, Halbert Hargrove Global Advisors LLC, Novem Group, Fortitude Family Office LLC, Dynamic Advisor Solutions LLC, Modern Wealth Management LLC, Quaker Wealth Management LLC, CTC LLC, Goldman Sachs Group Inc., Select Equity Group L.P., Parallax Volatility Advisers L.P., Millennium Management LLC, 683 Capital Management LLC, Nantahala Capital Management LLC, Cubist Systematic Strategies LLC, MAI Capital Management, Nomura Holdings Inc., DRW Securities LLC, Twin Tree Management LP, Susquehanna International Group LLP, Tortoise Investment Management LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, New Harbor Financial Group LLC, Capital Fund Management S.A., Credit Agricole S A, Hsbc Holdings PLC, Maven Securities LTD, Cresset Asset Management LLC, Persistent Asset Partners Ltd, HighTower Advisors LLC, Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, National Bank of Canada FI, Citigroup Inc., XY Capital Ltd, Gladius Capital Management LP, US Bancorp DE, Bedel Financial Consulting Inc., and Brandywine Oak Private Wealth LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.